Vallon Pharmaceuticals, Inc. announced that Penny S. Toren's position as Senior Vice President, Regulatory Affairs & Project Management was eliminated, effective immediately, as part of the Company's effort to streamline its operations in order to preserve its capital and cash resources and not as the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices or in any way for cause. The Company continues to work with its existing outside regulatory consultants to manage all submissions to and interactions with regulatory agencies, including the U.S. Food and Drug Administration.